BRAMANT Trademark
Trademark Overview
On Thursday, August 2, 2001, a trademark application was filed for BRAMANT with the United States Patent and Trademark Office. The USPTO has given the BRAMANT trademark a serial number of 76294805. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, November 20, 2005. This trademark is owned by Pfizer Inc.. The BRAMANT trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations and preparations for the treatment of gynecological disorders; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence
General Information
| Serial Number | 76294805 |
| Word Mark | BRAMANT |
| Filing Date | Thursday, August 2, 2001 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Sunday, November 20, 2005 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 27, 2002 |
Trademark Statements
| Goods and Services | pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations and preparations for the treatment of gynecological disorders; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 17, 2001 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
Trademark Events
| Event Date | Event Description |
| Tuesday, January 24, 2006 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Tuesday, January 24, 2006 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, April 26, 2005 | EXTENSION 5 GRANTED |
| Wednesday, March 30, 2005 | EXTENSION 5 FILED |
| Wednesday, March 30, 2005 | TEAS EXTENSION RECEIVED |
| Friday, October 22, 2004 | EXTENSION 4 GRANTED |
| Thursday, October 7, 2004 | EXTENSION 4 FILED |
| Thursday, October 7, 2004 | TEAS EXTENSION RECEIVED |
| Tuesday, August 3, 2004 | CASE FILE IN TICRS |
| Wednesday, July 14, 2004 | ASSIGNED TO EXAMINER |
| Wednesday, June 2, 2004 | ASSIGNED TO EXAMINER |
| Thursday, April 15, 2004 | EXTENSION 3 GRANTED |
| Thursday, April 15, 2004 | EXTENSION 3 FILED |
| Thursday, April 15, 2004 | TEAS EXTENSION RECEIVED |
| Monday, October 27, 2003 | EXTENSION 2 GRANTED |
| Monday, October 27, 2003 | EXTENSION 2 FILED |
| Monday, November 10, 2003 | PAPER RECEIVED |
| Thursday, October 30, 2003 | PAPER RECEIVED |
| Friday, May 30, 2003 | EXTENSION 1 GRANTED |
| Tuesday, April 29, 2003 | EXTENSION 1 FILED |
| Monday, April 28, 2003 | TEAS EXTENSION RECEIVED |
| Tuesday, November 19, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 27, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 7, 2002 | NOTICE OF PUBLICATION |
| Wednesday, May 29, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 8, 2002 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 14, 2001 | NON-FINAL ACTION MAILED |
| Wednesday, September 12, 2001 | ASSIGNED TO EXAMINER |
